Why the study?
Does MS-551 alter electrophysiological parameters in patients undergoing electrophysiological study?
Does MS-551 alter electrophysiological parameters in patients undergoing electrophysiological study?
MS-551 is a Class III antiarrhythmic agent that prolongs atrial and ventricular effective refractory periods and slightly decreases heart rate without affecting blood pressure or intracardiac conduction times in humans.
No takes yet. Share an insight, caveat, or question.
Supports exploration of MS-551 as antiarrhythmic; hypothesis-generating and does not yet inform practice.
Isomoto et al. (1995) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: